Depigmentation therapy in vitiligo universalis with topical 4- methoxyphenol and the Q-switched ruby laser

Journal of the American Academy of Dermatology

Volumn 42, Issue 5 I, 2000, Pages 760-769

  Njoo, M D ^a,b   Vodegel, R M ^a,c   Westerhof, W ^a,b,d  

^a Theological University Amsterdam Groningen   (Netherlands)

^b Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEQUINOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEPIGMENTATION; DRUG EFFECT; DRUG SAFETY; ESTHETICS; FEMALE; HUMAN; HUMAN TISSUE; LASER SURGERY; MALE; PRIORITY JOURNAL; PRURITUS; Q SWITCHED RUBY LASER; SKIN IRRITATION; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANISOLES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASERS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SKIN PIGMENTATION; VITILIGO;

EID: 0034106481     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.103813     Document Type: Article

References (27)

1. JJ Nordlund JP. Ortonne Vitiligo vulgaris JJ Nordlund RE Boissy VJ Hearing RA King JP Ortonne The pigmentary system: physiology and pathophysiology 1998 Oxford University Press New York 513 551
2. MD Njoo PI Spuls JD Bos W Westerhof PMM. Bossuyt Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature Arch Dermatol 134 1998 1532 1540
3. MD Njoo W Westerhof JD Bos PMM. Bossuyt A systematic review of autologous transplantation methods in vitiligo Arch Dermatol 134 1998 1543 1549
4. DB Mosher JA Parrish TB. Fitzpatrick Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and a review of the literature Br J Dermatol 97 1977 669 679
5. C Antoniou A. Katsambas Guidelines for the treatment of vitiligo Drugs 43 1992 490 498
6. LA Drake SM Dinehart ER Farmer RW Goltz GF Graham MK Hordinsky Guidelines of care for vitiligo J Am Acad Dermatol 35 1996 620 626
7. PE. Grimes Vitiligo: an overview of therapeutic approaches Dermatol Clin 11 1993 325 338
8. TR Hedges KR Kenyon LA Hanninen DB. Mosher Corneal and conjunctival effects of monobenzone in patients with vitiligo Arch Ophthalmol 101 1983 64 68
9. JJ Nordlund B Forget J Kirkwood AB. Lerner Dermatitis produced by applications of monobenzone in patients with active vitiligo Arch Dermatol 121 1985 1141 1144
10. AM. Oakley Rapid repigmentation after depigmentation therapy: vitiligo treated with monobenzyl ether of hydroquinone Australas J Dermatol 37 1996 96 98
11. PA. Riley Hydroxyanisole depigmentation: in vivo studies J Pathol 97 1969 185 191
12. PA. Riley Hydroxyanisole depigmentation: in vitro studies J Pathol 97 1969 193 206
13. PA. Riley Mechanism of pigment cell toxicity produced by hydroxyanisole J Pathol 101 1970 163 169
14. JEF. Reynolds Dermatological agents: mequinol 29th ed JEF Reynolds Martindale. The extra pharmacopoeia 1612-b 1989 The Pharmaceutical Press London 923
15. J Boyle CTC. Kennedy British cosmetic regulations inadequate Br Med J 288 1984 1998 1999
16. D. Colomb Depigmentation en confettis après application de Leucodinine B sur chloasma Ann Dermatol Venereol 109 1982 899 900
17. MS Spicer DJ. Goldberg Lasers in dermatology J Am Acad Dermatol 34 1996 1 25
18. M Thissen W. Westerhof Laser treatment for further depigmentation in vitiligo Int J Dermatol 36 1997 386 388
19. CI Le Poole RMGJ van den Wijngaard W Westerhof RP Dutrieux PK Das Presence or absence of melanocytes in vitiligo lesions J Invest Dermatol 100 1993 816 822
20. DG. Altman Practical statistics for medical research DG Altman 1997 Chapman and Hall London 179 277
21. ML Gardner DG Altman Statistics in medicine 1989 British Medical Journal London
22. MA Pathak TB. Fitzpatrick Preventive treatment of sunburn, dermatoheliosis and skin cancer with sun-protective agents 4th ed TB Fitzpatrick AZ Eisen K Wolff IM Freedberg FK Austen Dermatology in general medicine 1993 McGraw-Hill New York 1689 1717
23. R. Brun Contribution à l’etude de la depigmentation experimentale Dermatologica 118 1959 202
24. J Boyle CTC. Kennedy Leucoderma induced by monomethylether of hydroquinone Clin Exp Dermatol 10 1985 154 158
25. SW Becker MC. Spencer Evaluation of monobenzone JAMA 180 1962 279 284
26. MD Njoo PK Das JD Bos W. Westerhof Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris Arch Dermatol 135 1999 407 413
27. J Grevelink RL van Leeuwen RR Anderson R. Byers Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers Arch Dermatol 133 1997 349 353